Drug Product Development, WuXi Biologics Inc., No. 1951 Huifeng West Rd., 201401 Shanghai City, China.
Drug Product Development, WuXi Biologics Inc., No. 1951 Huifeng West Rd., 201401 Shanghai City, China.
Eur J Pharm Biopharm. 2024 Apr;197:114221. doi: 10.1016/j.ejpb.2024.114221. Epub 2024 Feb 18.
The development of PFS requires a detailed understanding of the forces occurring during the drug administration process and patient's capability. This research describes an advanced mathematic injection force model that consisting hydrodynamic force and friction force. The hydrodynamic force follows the basic law of Hagen-Poiseuille but refines the modeling approach by delving into specific properties of drug viscosity (Newtonian and Shear-thinning) and syringe shape constant, while the friction force was accounted from empty barrel injection force. Additionally, we take actual temperature of injection into consideration, providing more accurate predication. The results show that the derivation of the needle dimension constant and the rheological behavior of the protein solutions are critical parameters. Also, the counter pressure generated by the tissue has been considered in actual administration to address the issue of the inaccuracies of current injection force evaluation preformed in air, especially when the viscosity of the injected drug solution is below 9.0 cP (injecting with 1 mL L PFS staked with 29G ½ inch needle). Human factor studies on patients' capability against medication viscosity filled the gap in design space of PFS drug product and available viscosity data in very early phase.
PFS 的发展需要详细了解药物给药过程中发生的力和患者的能力。本研究描述了一个先进的数学注射力模型,它由流体动力和摩擦力组成。流体动力遵循哈根-泊肃叶基本定律,但通过深入研究药物粘度(牛顿和剪切稀化)和注射器形状常数的具体特性来改进建模方法,而摩擦力则来自空筒注射力。此外,我们还考虑了实际的注射温度,提供更准确的预测。结果表明,针头尺寸常数的推导和蛋白质溶液的流变行为是关键参数。此外,还考虑了组织产生的反压,以解决当前在空气中进行的注射力评估不准确的问题,特别是当注射药物溶液的粘度低于 9.0 cP 时(用 29G ½ 英寸针头注射 1 mL L PFS)。针对患者对药物粘度的耐受力的人体因素研究填补了 PFS 药物产品设计空间和早期可用粘度数据的空白。